114 related articles for article (PubMed ID: 27084135)
1. [The risk is higher, but why?].
Stiefelhagen P
MMW Fortschr Med; 2016 Mar; 158(6):18. PubMed ID: 27084135
[No Abstract] [Full Text] [Related]
2. Metformin and risk of hepatocellular carcinoma: are statins the missing link?
Singh S; Singh PP
Gut; 2013 Jun; 62(6):951-2. PubMed ID: 23263525
[No Abstract] [Full Text] [Related]
3. Authors' response: Metformin and risk of hepatocellular carcinoma--a study focused on anti-diabetic agents.
Wu CY; Chen HP
Gut; 2013 Jun; 62(6):952. PubMed ID: 23355550
[No Abstract] [Full Text] [Related]
4. Diabetes and pancreatic cancer: chicken or egg?
Magruder JT; Elahi D; Andersen DK
Pancreas; 2011 Apr; 40(3):339-51. PubMed ID: 21412116
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ; Moss RA
Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome.
Cauchy F; Mebarki M; Albuquerque M; Laouirem S; Rautou PE; Soubrane O; Raymond E; Bedossa P; Paradis V
Gut; 2015 Sep; 64(9):1498-500. PubMed ID: 26123027
[No Abstract] [Full Text] [Related]
7. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
8. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.
Chen HP; Shieh JJ; Chang CC; Chen TT; Lin JT; Wu MS; Lin JH; Wu CY
Gut; 2013 Apr; 62(4):606-15. PubMed ID: 22773548
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and screening for hepatocellular carcinoma.
Spivey JR; Gores GJ
Compr Ther; 1992 Jun; 18(6):5-9. PubMed ID: 1324826
[No Abstract] [Full Text] [Related]
10. [Hepatocellular carcinoma. Unifying our efforts].
Barbare JC
Rev Prat; 2004 Mar; 54(6):587-90. PubMed ID: 15222607
[No Abstract] [Full Text] [Related]
11. [Is follow up of hepatocellular carcinoma in patients with liver cirrhosis justified?].
Prat F
Gastroenterol Clin Biol; 1992; 16(11):910. PubMed ID: 1282892
[No Abstract] [Full Text] [Related]
12. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
Tajima K; Nakamura A; Shirakawa J; Togashi Y; Orime K; Sato K; Inoue H; Kaji M; Sakamoto E; Ito Y; Aoki K; Nagashima Y; Atsumi T; Terauchi Y
Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E987-98. PubMed ID: 23964070
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors and prevention of hepatocellular carcinoma].
Tanaka K
Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
[No Abstract] [Full Text] [Related]
14. Coffee and the risk of hepatocellular carcinoma: misleading analysis of the data.
Huang XY; Hu C
Eur J Cancer Prev; 2018 Jul; 27(4):315. PubMed ID: 29688907
[No Abstract] [Full Text] [Related]
15. [Prevention of hepatocellular carcinogenesis by interferon].
Ikeda K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():755-63. PubMed ID: 11762051
[No Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma in Pakistan.
Abbas Z
J Coll Physicians Surg Pak; 2013 Nov; 23(10):769-70. PubMed ID: 24169381
[No Abstract] [Full Text] [Related]
17. [Retinoid].
Moriwaki H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():764-8. PubMed ID: 11762053
[No Abstract] [Full Text] [Related]
18. [Screening for hepatocellular cancer].
Lithner F; Andersson C
Lakartidningen; 1999 Apr; 96(16):1944, 1947. PubMed ID: 10330860
[No Abstract] [Full Text] [Related]
19. Prevention of hepatocellular carcinoma.
Kew MC
S Afr J Surg; 2011 Apr; 49(2):50-1, 86. PubMed ID: 21614973
[No Abstract] [Full Text] [Related]
20. [Prevention of hepatocellular carcinoma].
von Weizsäcker F; Allgaier HP; Blum HE
Praxis (Bern 1994); 2002 Aug; 91(35):1393-5. PubMed ID: 12233281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
